11:45 am – 12:00 pm – Registration & Lunch
12:00 pm – 12:30 pm – Case 1: Aggressive Approaches to the WHO-1 Patient
12:30 pm – 1:00 pm – Case 2: Screening and Aggressive Care in the SSc/PH Patient
Vallerie McLaughlin, MD
Kim A. Eagle Endowed Professor of Cardiovascular Medicine Department of Internal Medicine/Cardiovascular Medicine
University of Michigan
Richard Channick, MD
Professor of Medicine
Pulmonary and Critical Care Division
David Geffen School of Medicine, UCLA
Ioana Preston, MD
Associate Professor of Medicine
Director, Pulmonary Hypertension Center
Director, Pulmonary Function Test Lab
Tufts Medical Center
Victor Tapson, MD
Professor of Medicine
Division of Pulmonary and Critical Care
Cedars-Sinai Medical Center
This activity has been designed to meet the educational needs of physicians and other healthcare professionals involved in the care of patients with pulmonary hypertension.
After completing this activity, the participant should be better able to:
- Describe the latest data supporting the new and emerging PAH medications and delivery systems
- Discuss the use of aggressive combination therapy approaches to PAH
- Describe the components of the PH specialty center and how integration with primary care can benefit PAH patients
- Utilize current and emerging practice guidelines for Group 1 PAH and non-Group 1 PH
- Explain the timing of various therapies in the course of the patient's disease and whether earlier action on the prostacyclin pathway alone or in combination therapy benefits patients clinically
- Illuminate the rationale for switching therapies to take advantage of alternative attack points in PAH pathophysiology
- Present up-to-date clinical evidence regarding new treatment modalities and development programs.
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute
for Medicine and Total CME. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for
Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American
Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician Continuing Medical Education
The Postgraduate Institute for Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosure of Conflicts of Interest
Postgraduate Institute for Medicine (PIM) requires instructors, planners, managers and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest (COI) they may have as related to the content of this activity. All identified COI are thoroughly vetted and resolved according to PIM policy. PIM is committed to providing its learners with high quality activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.
Americans with Disabilities Act
Event staff will be glad to assist you with any special needs (i.e., physical, dietary, etc.). Please contact Total CME prior to the live event at (267) 395-0001.
There is no fee for this educational activity.
Jointly provided by Postgraduate Institute for Medicine and TotalCME.
This activity is supported by an independent educational grant from Actelion Pharmaceuticals US, Inc.